You just read:

CytoSorb® is Approved and Available for the Removal of Ticagrelor, a Leading Anti-Platelet Drug, During Cardiopulmonary Bypass in the E.U.

News provided by

CytoSorbents Corporation

Jan 29, 2020, 07:25 ET